While the hypothalamic-hypophysial portal system has been extensively studied in laboratory animals, equivalent studies have not been performed in humans. Here, we present an experimental procedure for collecting suprapituitary blood in man. To solve the question on the origin of such blood we investigated specific markers of hypothalamic secretory activity: the catecholamines (CAs). We found (a) norepinephrine (NE), dopamine (DA), and epinephrine (E) concentrations from 1.5 to 2.5, 3.5 to 4.5, and 6-to 10-fold higher, respectively, in suprapituitary than peripheral blood, (b) different NE/DA and NE/E ratios in favor of DA and E in suprapituitary blood, and (c), a complete (100%) group separation (suprapituitary vs. peripheral) when discriminant analysis included only DA and E. These data indicate that suprapituitary blood composition is different from that of the peripheral blood, and is particularly rich in CAs and claimed differences between DA and E release on one hand and NE release on the other in suprapituitary blood also are observed. We advance the hypothesis of a hypothalamic source of such amines draining via median eminence into portal vasculature, and name this blood "hypothalamic-hypophysial blood." Besides serving as "classical" neurotransmitters, CAs may also have a direct neurohormonal role in the regulation of the human hypothalamic-hypophysial function.
Introduction
The hypothalamic-hypophysial portal system has been extensively studied in several mammal species. Portal blood has been collected by different techniques (1) (2) (3) , by different surgical approaches (2, 4) and in different topographic sites (4) . In man, no reports on suprapituitary blood collections have been reported in literature; only studies on intrapituitary blood (4) (5) (6) or blood from inferior petrosal sinuses (7, 8) exist.
We have developed an experimental method for collecting blood from the suprapituitary region in men with nonfunctioning pituitary disease that makes use of transsphenoidal microsurgery. This procedure should make it possible to gain new insights into the endocrine mechanisms regulating the human hypothalamic-hypophysial axis. However, the question regarding the origin ofthe collected blood and the need of locating, with precision, its source immediately arises. To address this question we investigated specific markers of the hypothalamic secretory activity. Catecholamines (CAs)l are abundant in discrete regions of the rat brain including the hypothalamus (9) and median eminence (10) . In particular, reticulo-hypothalamic norepinephrine (NE), and epinephrine (E), neuron systems project terminals to various hypothalamic areas including the arcuate nucleus (1 1), and the tuberoinfundibular dopamine (DA) neuron system is present in the arcuate nucleus with projections to the median eminence (12) . These CA neuron systems also exist in human brain (13) . Anterior pituitary tissue contains very low or undetectable CA concentrations, and posterior pituitary tissue contains assayable amounts of DA in rats (9, 10) .
The vascularization of the human pituitary gland has long been debated, however, it is commonly accepted that most of the blood supply to the adenohypophysis is derived from the hypothalamic-hypophysial portal system (14) . Considering that CA concentrations in hypothalamic-hypophysial portal blood may reflect hypothalamic secretory patterns, we deliberately assumed that the CA concentration gradient in suprapituitary vs. peripheral blood is an index of hypothalamic catecholaminergic function. To test this assumption, we have made use of a highly sensitive and fully automated analytical procedure that utilized high performance liquid chromatography with electrochemical detector (HPLC-ED) (15, 16 ). This method makes it possible to quantify DA, NE and E simultaneously in minute volumes of plasma, a requirement for investigations on suprapituitary blood in man.
Methods 12 normotensive subjects (Table I) , with clinical appearance and radiological findings (high resolution computed tomography and magnetic resonance imaging) of pituitary adenoma, but with no claimed endocrine disturbances of hypothalamic-hypophysial function, entered the study after informed consent was obtained. A detailed endocrine workup was obtained in all subjects. Plasma growth hormone (GH), thyroid stimulating hormone (TSH), adrenocorticotropic hormone (ACTH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), 1703-estradiol, testosterone, progesterone, cortisol, dehydroepiandrosterone sulfate, thyroxine, and triiodothyronine 1. Abbreviations used in this paper: CA(s), catecholamine(s); DA, dopamine; E, epinephrine; FSH, follicle-stimulating hormone; GH, growth hormone; GnRH, gonadotropin-releasing hormone; HHB, hypothalamic-hypophysial blood; HPLC-ED, high performance liquid chromatography with electrochemical detector, LH, luteinizing hor- The human pituitary stalk and gland region was approached via a transsphenoidal route (19) . Tumor removal was carried out selectively and as radically as possible. Collection of suprapituitary blood was accomplished under both direct microscopic and fluoroscopic control. It consisted of periodically aspirating blood by a microsuction apparatus ( Fig. 1) , just after tumor removal. The tip of the microcannula of the aspirator was kept in the postero-superior corner ofthe sella turcica at the junction of the diaphram sellae with the dursum sellae where the pituitary stalk, against which the tip was leaning, passes. Under microscopic control, the infundibular stem and process of the neurohypophysis could be distinguished from adenohypophysis, even though a thick collar of the residua pars tuberalis covered the infundibular stem. From the microsuction apparatus, blood was directed into small polypropylene tubes containing appropriate preservatives for different hormonal studies, without substantially prolonging the surgical procedure. In particular, six blood samples of0.5-0.6 ml each were collected over a 30-to 60-s period at 2-min intervals. The problems of blood contamination were minimized by the following: (a) filtration of any bits of nervous or tumor tissue by means of an in-line support system (Millipore Corp., Bedford, MA) containing 100-mesh nylon gauze (Schweiz Seidengazes Fabrik AG, St. Gallen, Switzerland), which was interposed between the microaspirator and the collecting tubes, (b) simultaneous use of a second, larger suction device, situated in the sella, to remove extraneous blood (Fig. 1) , and (c) evaluation of microhematocrits of each aspirate to exclude dilution due to mixing with cerebrospinal fluid.
In all subjects, six control samples (each of 5 ml, 30 ml total) of peripheral venous blood were collected simultaneously by the anesthesiologist (day 0, operative condition). Moreover, additional samples of peripheral blood were obtained (0800 to 1000 hours) 3 d before (day -3, basal condition) and 3 d after the operative (day +3, replacement therapy condition). After inserting a venous line the patients were kept for at least 60 min in semirecumbent position before sampling. A blood sample (30 ml) was collected and, then, divided in six aliquots of 5 ml each.
In all blood samples, plasma was immediately separated and stored at -70°C until analyzed. DA, NE and E concentrations were determined by HPLC-ED (Fig. 2) (15, 16) . Briefly, plasma CAs were complexed with diphenylboronic acid "2-aminoethyl diphenylborinate" and the complex was extracted on reversed-phase C 18 cartridge. The cartridge was eluted by column-switching with the HPLC-ED mobil phase, and the CAs were separated by the HPLC analytical column.
The analyzer diluted 300-id aliquots of peripheral plasma with 600 ;d ofbuffer containing the complexing agent and 100-or 50-,gl aliquots of suprapituitary plasma with 800 or o50 Ml, respectively, of buffer, depending on sample volume (Fig. 2) . The intraassay (interassay) variability were 1.9% (3.5%), 2.1% (3.8%), and 2.0 (3.7%) for NE, E, and DA, respectively. The minimum plasma concentration detectable was: 6, 11, and 20 pmol/liter for NE, E, and DA, respectively.
Statistical analysis was performed by using nonparametric paired Wilcoxon rank test. Discriminant analysis (Wilks' method in SPSS discriminant procedure on log-transformed variables) was also performed to distinguish between suprapituitary and peripheral (day 0) blood (20). 
Results
Individual and mean CA concentrations are reported in Table  I and Fig. 3 , respectively. The mean (±SEM) CA concentration gradient in suprapituitary vs. peripheral blood in day 0 was 4.0±0.6, 1.5±0.2, and 7.7±2.4 for DA, NE, and E, respectively. In particular, suprapituitary CA concentrations were markedly (DA, P < 0.003 and E, P < 0.002) and less markedly (NE, P < 0.04) higher than peripheral concentrations (day 0) (Fig. 3) . No significant differences among the three peripheral uday 0 -.. conditions were observed for DA and E, whereas differences (P < 0.01) were observed for NE between day 0 and both day -3 and +3.
The mean (±SEM) NE/DA and NE/E ratios were significantly different in peripheral (day 0) vs. suprapituitary blood (7.7±1.0 vs. 3.2±0.5, P < 0.005, for NE/DA; 7.0±1.3 vs. 2.1±0.6, P < 0.03, for NE/E), whereas E/DA ratio showed no significant difference.
Finally, a discriminant function was calculated in order to evaluate the ability of the variables, DA, NE, E, to distinguish between suprapituitary and peripheral (dayO) blood. Only PA and E were entered into the function (F = 1.587 X log DA + 1.619 X log E -18.039). Based on the discriminant scores, all the subjects (100%) were correctly classified (Fig. 4) .
Discussion
In the study CA concentrations in peripheral conditions are somewhat more uniform and cQnsistent with thQse reported in man by radioenzymatic (21, 22) or by the same HPLC-ED techniques (23). The manifest gap in CA concentrations and the different inter-CA ratios in suprapituitary versus peripheral blood are a novel finding in man. Since both suprapituitary and peripheral blood were collected simultaneously during surgery, anesthesia and surgical stress do not interfere with the concentration gap, even though such stressors activate periphirally (day -3 to day 0) catecholaminergic stimulation, in which NE release predominates (Fig. 3) , confirming previous observations (221). The arterial-venous differences observed in the periphery (24) also do not explain the CA concentration gradient. Furthermore, no gross contamination with pieces of infundibular tissue could contribute to these differences because the blood was filtered during collection. Since surgery was performed at different hours, the simultaneous sampling of blood on day 0 obviates interference due to circadian rhythms of plasma CAs (22) . Hemodynamic parameters also may influence CA regulation (25) , but the subjects studied -30 -'3 day Figure 3 . DA, NE and E concentrations in the study period in peripheral (preoperatively: day -3; operatively: day 0; postoperatively: day +3) and suprapituitary blood. Each bar represent the mean±SEM for 12 subjects. Note the higher CA concentrations in the suprapituitary blood than in the peripheral. *P < 0.04, **P < 0.007, ***P < 0.003, ****P < 0.002 vs. suprapituitry blood. (27) in hypophysial portal than in peripheral blood, whereas NE concentrations are similar (28) .
The data lead us to emphasize that in man, besides from a peripheral source, such as adrenal medulla for E and sympathetic neurons for NE (29) 
